Skip to content

Drug interactions

Elvitegravir / cobicistat / emtricitabine / tenofovir df + Primaquine

Severity: Moderate

Elvitegravir / cobicistat / emtricitabine / tenofovir df and Primaquine: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Cobicistat inhibits CYP3A4 and may raise primaquine concentrations. Primaquine can cause dose-related hemolysis in G6PD deficiency and has QT-prolonging potential, so higher exposure could increase toxicity. Clinical data are limited and the effect is mainly predicted.

What this interaction means in plain words

Elvitegravir / cobicistat / emtricitabine / tenofovir df and Primaquine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Low

Why it happens

Cobicistat inhibits CYP3A4 and may reduce primaquine metabolism.

What to do

Monitor for adverse effects such as hemolysis, methemoglobinemia and QT changes, and obtain an ECG if other QT-prolonging drugs are used. Confirm G6PD status before primaquine.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Elvitegravir / cobicistat / emtricitabine / tenofovir df and Primaquine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Elvitegravir / cobicistat / emtricitabine / tenofovir df with Primaquine?

MediHelp rates the interaction as moderate. Elvitegravir / cobicistat / emtricitabine / tenofovir df and Primaquine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Cobicistat inhibits CYP3A4 and may raise primaquine concentrations. Primaquine can cause dose-related hemolysis in G6PD deficiency and has QT-prolonging potential, so higher exposure could increase toxicity. Clinical data are limited and the effect is mainly predicted.

How serious is the interaction between Elvitegravir / cobicistat / emtricitabine / tenofovir df and Primaquine?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for adverse effects such as hemolysis, methemoglobinemia and QT changes, and obtain an ECG if other QT-prolonging drugs are used. Confirm G6PD status before primaquine.

What other medicines interact with Primaquine?

MediHelp also lists interactions of Primaquine with, for example, Pimozide, Amiodarone, Amisulpride. The full list is on the Primaquine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in